936 results on '"Pribram, Karl"'
Search Results
202. Evidence That Amyloid Pathology Progresses in a Neurotransmitter-Specific Manner.
203. Cellular Membranes as Targets in Amyloid Oligomer Disease Pathogenesis.
204. Ganglioside-Dependent Generation of a Seed for Alzheimer's Disease Amyloid.
205. Frequency and Relation of Argyrophilic Grain Disease and Thorn-Shaped Astrocytes in Alzheimer's Disease.
206. Up-regulation of the α-Secretase Pathway.
207. Pleiotropic Effects of Apolipoprotein E in Dementia: Influence on Functional Genomics and Pharmacogenetics.
208. Enhanced Activation of NF-κB Signaling by Apolipoprotein E4.
209. Co-expression of FTDP-17 Human Tau and GSK-3ß (or APPSW) in Transgenic Mice: Induction of Tau Polymerization and Neurodegeneration.
210. Cell Models of Tauopathy.
211. Critical Acute Akinesia in Parkinson's Disease Patients Concomitant with Additional Precipitating Factors Other Than Treatment Withdrawal: A Possible Lethal Complication.
212. Expression of Wnt Receptors, Frizzled, in Rat Neuronal Cells.
213. Physiological Processing of the Cellular Prion Protein and βAPP: Enzymes and Regulation.
214. Intraneuronal Aβ and Alzheimer's Disease.
215. Neuroprotective Effects of Trophic Factors and Natural Products: Involvement of Multiple Intracellular Kinases.
216. Shift in the Balance of TRKA and ProNGF in Prodromal Alzheimer 's Disease.
217. Decreased ProBDNF: The Cause of Alzheimer's-Associated Neurodegeneration and Cognitive Decline?
218. Oral Aβ Vaccine Using a Recombinant Adeno-Associated Virus Vector in an Alzheimer's Disease Mouse Model.
219. Prospective Role of Glycosaminoglycans in Apoptosis Associated with Neurodegenerative Disorders.
220. Stem Cell Therapy in Alzheimer's Disease.
221. Glycosaminoglycans and Analogs in Neurodegenerative Disorders.
222. Cholesterol and Aβ Production: Methods for Analysis of Altered Cholesterol De Novo Synthesis.
223. Cholesterol Transport and Production in Alzheimer's Disease.
224. Vascular Risk Factors and Risk for Alzheimer's Disease and Mild Cognitive Impairment: Population-Based Studies.
225. Two Hits and You're Out? A Novel Mechanistic Hypothesis of Alzheimer Disease.
226. Alzheimer's Disease Neuroimaging Initiative.
227. Bioluminescent Imaging of Excitotoxic and Endotoxic Brain Injury in Living Mice.
228. Biomarkers for Alzheimer's Disease and Parkinson's Disease.
229. Redox Proteomics Identification of Oxidatively Modified Proteins in Alzheimer's Disease Brain and in Brain from a Rodent Model of Familial Parkinson's Disease: Insights into Potential Mechanisms of Neurodegeneration.
230. Role of Oxidative Insult and Neuronal Survival in Alzheimer's and Parkinson's Diseases.
231. Alzheimer's Disease, Parkinson's Disease, and Frontotemporal Dementias: Different Manifestations of Protein Misfolding.
232. Neuroinflammation in Early Stages of Alzheimer's Disease and Parkinson's Disease.
233. Dissecting the Biochemical Pathways Mediated by Genes Implicated in Parkinson's Disease: Induction of DJ-1 Expression in A30P α-Synuclein Mice.
234. Microglia Activation and Gene Expression of Cytokines in Parkinson's Disease.
235. LRRK2 (Leucine-Rich Repeat Kinase 2) Gene on PARK8 Locus in Families with Parkinsonism.
236. Novel Therapeutic Target in PD: Experimental Models.
237. Biomarkers for Early Detection of Parkinson's Disease: An Essential Challenge.
238. Neurotransmitter and Neurotrophic Factor-Secreting Cell Line Grafting for the Treatment of Parkinson's Disease.
239. Current Problems and Strategies in Motor Rehabilitation for Parkinson's Disease.
240. Impaired DNA Repair Systems: Generation of Mitochondrial Dysfunction and Increased Sensitivity to Excitotoxicity.
241. Neurogenetics in Parkinson's Disease.
242. Clinical Features and Treatment of Dementia Associated With Parkinson's Disease.
243. Pribram and MacLean in Perspective
244. Amygdala Metabotropic Glutamate Receptors and Kindling.
245. Clinical Evidence of Epilepsy-Related Plasticity.
246. Pathological Sensitization of the Dopamine System in Experimental Epileptogenesis.
247. Natural History of Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis.
248. Predisposed Susceptibility in Primate Epileptogenesis and Anti-Epileptogenesis.
249. General Discussion 2.
250. Low Frequency Sine Wave Stimulation Decreases the Incidence of Kindled Seizures.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.